online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
  • 2 of 9
ECPB 2020, 89(1): 15–22
Research articles

Characteristics of antioxidant and NO-synthase systems of blood lymphocytes under the action of decamethoxine


Antiseptic drugs have mostly microbicidal effect on the skin surface, mucous membranes, surfaces of a wound and body cavities. Decamethoxine is a chemical compound [1, 10-decamethylene bis (N, N – dimethylmethoxycarbonylmethyl) ammonium dichloride] that has a wide range of antimicrobial actions on Gram-positive (staphylococcus, streptococcus, pneumococcus), Gram-negative (gonococcus, meningococcus) cocci, diphtheria corynebacteria, enterobacteria, pseudomonads, protozoa, dermatophytes, yeasts-like fungi of the genus Candida, chlamydia and viruses. Pathological processes that occur in the cells of the body when inflammatory processes and pathological conditions are caused primarily by the violation of regulatory systems, the activation of lipid peroxidation processes and the violation of antioxidant protective system. Since decamethoxine has hydrophilic and lipophilic properties, it can penetrate into cells, blood through surfaces of a wound, mucous membranes, skin, etc., and be transmitted by blood to different organs and tissues, thus causing a variety of biochemical effects, particularly regarding to the regulatory NO-synthase system of cells. In this respect the biological action of decamethoxine has not been investigated substantially. Since the intracellular lymphocyte metabolism is based on the physiologically- and biochemically- fixed ability of these cells to respond quickly to any changes in homeostasis in the body, they can be a convenient and adequate model for the study of pathophysiological and regulatory disorders in the organism. We have conducted a comparative study of the LPO system and glutathione in peripheral blood lymphocytes under the action of decamethoxine. A slight inhibition of LPO processes under the action of different concentrations of decamethoxine is shown which was evaluated by determining the concentration of malondialdehyde, being a secondary product of lipid peroxidation. Thus, the concentration of MDA in blood lymphocytes is (62,3±4,6) nmol/mg of protein in the control group, while under the influence of different concentrations of decamethoxine (10-5 – 10-2 M) this value decreases to (55,1±4,3) μmol/mg of protein (p>0,001). Significant changes in blood cells in the process of lipid peroxidation have been observed when they are not exposed to decamethoxine, however, there is a tendency to decrease. Simultaneously, with a slight decrease in the process LPO, the appropriate changes in the activity of glutathione system enzymes were revealed. Thus, it was shown that lymphocyte glutathione peroxidase activity is (154,2±13,4) nmol GSH/min∙mg of protein in the control group. Under the action of decamethoxine, this activity increases dose-dependently and reaches 181,2±13,3) nmol GSH/min∙mg of protein (p < 0,05). However, the concentration of reduced glutathione under the action of decamethoxine remained virtually unchanged and ranged from 17,2 to 18,4 nmol GSH/mg of protein. Glutathione S-transferase activity was (112,2±9,2) nmol GSH/min∙mg of protein in the control group. While being added to the incubation medium of decamethoxine at concentrations of 10-5−10-2M, this enzyme was activated dose-dependently, its activity increased to (156,6±12,4) nmol GSH/min∙mg of protein, that is in 1,4 times (p<0,05). The effect of decamethoxine on the activity of the arginase-NO-synthase system of blood lymphocytes was also demonstrated. Decamethoxine dose-dependent activated arginase activity up to (175,1±8,8) nmol urea/min∙mg of protein at 10-2 M concentration, that is 1,4 times relatively to the control group (p<0,05). It has been established that the cNOS activity of blood lymphocytes in the control group was 71,4±6,9 and the activity of the inducible isoform 1,58±0,18 nmol NADPH(H+)/min∙mg of protein. With the action of decamethoxine at a concentration of 10-5 M, the activity of cNOS decreased in 1,25 times (p<0,05) while the activity of iNOS increased in 10,8 times (p<0,001). Thus, it has been found that decamethoxine significantly influences the regulatory mechanisms of the cell, blood lymphocytes in particular. It activates the enzymes of the glutathione antioxidant system, stimulates the activity of arginase and inhibits the activity of the constitutive isoform of NO synthase with the simultaneous activation of the inducible isoform of NO synthase.

Recieved: 26.02.20

Keywords: decamethoxine, lymphocytes, glutathione, arginase, NO-synthase

Full text: PDF (Eng) 340K

  1. 1. Gonchar OO, Nazarchuk OA, Paliy DV, Kovalenko IV, Yatsula OV, Burkot VM. The research of the activity of decamothoxin and its medicinal forms on adhession of bacteria. Jour- nal World of Medicine and Biology. 2015. 4(54):109-112 (in Ukrainian).
  2. 2. Nazarchuk OA, Chereshniuk IL, Nazarchuk GG, Palii DV. Current antiseptics: a study on their antimicrobial activity and toxic effects on the corneal epithelium. Journal Ophthalmology. 2019;3:26-31.
  3. 3. Nazarchuk OA, Paliy VG, Gonchar OO, Oliynyk DP, Nazarchuk GG, Paliy IG. The microbiological analysis of the effectiveness of modern antiseptics and antimicrobial materials. Clinical pharmacy. 2014;18(4):8-11 (in Ukrainian).
  4. 4. Paliy VG, Nazarchuk OA, Paliy DV, Iakovets KI. Substantiation of medical use of antimicrobial remedies, containing decamethoxin. Bukovinian Medical Herald. 2017;21(1):100- 105 (in Ukrainian).
  5. 5. Pashynskaya VA, Kosevich MV, Gomory A, Vashchenko OV, Lisetski LN. Mechanistic investigation on the interaction between bisquaternary antimicrobial agents and phospholipids by liquid secondary ion mass spectrometry and differential scanning calorimetry. Rapid Communication in Mass Spectrometry. 2002;16(18):1706-13.
  6. 6. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanism of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity. 2014;2014:1-31.
  7. 7. Birben E, Sahiner MU, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ Journal. 2012;5(1):9-19.
  8. 8. Bolin A, Guerra B, Nascimento S, Otton R. Change in lymphocyte oxidant/antioxidant parameters after carbonyl and antioxidant exposure. Intern. Immunopharmacology. 2012;14(4):690-97.
  9. 9. Gautam N, Das S, Mahapatra SK, Chakraborty SP, Kundu PK, Roy S. Age associated oxidative damage in lymphocytes. Oxidative Medicine and Cellular Longevity. 2010;3(4):275-82.
  10. 10. Jurcovic S, Osredkar J, Marc J. Molecular impact of glutathione peroxidases in antioxidant processes. Biochemia Medica. 2008;18(2):162-74.
  11. 11. Fafula RV, Iefremova UP, Luchkovska NE, Vorobets ZD, Kulachkovskii O.R. Methodological approach to the study of the enzymatic spectrum of lymphocytes at pathological states using a detergent of saponin (ultrastructural study). Visnyk Problem Biologii i Medecini. 2012;1(96):163-66 (in Ukrainian).
  12. 12. Peretiatko YuV, Sybirna NO. Pecularities of arginase and NO-synthase pathways of L-arginine metabolism in leucocytes of peripheral blood of rats in conditions of chronic x-ray irradiation]. Ukrainskii Biokhimicheskii Zhurnal. 2009 Mar-Apr;81(2):40-8 (in Ukrainian).
  13. 13. Ochoa A, Zea H, Hernandez C, Rodriguez PC. Arginase, prostaglandins, and myeloid- derived suppressor cells in renal cell carcinoma. Clinical Cancer Research. 2007;13:721-26.
  14. 14. Kovalenko IV, Onufrovych OK, Melnyk OV, Korchynska OS, Vorobrts NM, Vorobets ZD. Effect of fluoroquinolones jn the activity of the glutathione system in the peripheral blood lymphocytes. Experimental and Clinical Physiology and Biochemistry. 2019;3(87):23-9.
  15. 15. Kovalenko IV, Onufrovych OR, Vorobets NM, Melnyk OV, Vorobets ZD. Arginase/NO- synthase system characteristics n blood lymphocytes under effect of fluoroquinolones. Regulatory Mechanisms in Biosystems. 2019;10(2):203-8.

Програмування -